alexa Are Cattle a Surrogate Model for Pathogenic Mycobacterial Latent Infection? | OMICS International
ISSN: 2161-1068
Mycobacterial Diseases
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Are Cattle a Surrogate Model for Pathogenic Mycobacterial Latent Infection?

Angel H Alvarez-Herrera1* and Mario Alberto Flores-Valdez2

1Department of Microbiology, Centro de Investigacions, Mexico

2Centro de Investigacions, México

Corresponding Author:
Angel H Alvarez
Centro de Investigacions, México
Tel: +52 (33) 3345-5200
Fax: +52-33-3345-5200
E-mail: [email protected]

Received Date: June 20, 2014; Accepted Date: June 25, 2014; Published Date: June 30, 2014

Citation: Alvarez-Herrera AH and Flores-Valdez MA (2014) Are Cattle a Surrogate Model for Pathogenic Mycobacterial Latent Infection?. J Mycobac Dis 4:e129. doi:10.4172/2161-1068.1000e129

Copyright: © 2014 Alvarez-Herrera AH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Mycobacterial Diseases

Editorial

Tuberculosis (TB) in humans is often produced as a consequence of infection with Mycobacterium tuberculosis, followed in number of cases by Mycobacterium bovis , that also causes bovine TB. M. tuberculosis is predominantly a human pathogen causing active TB in approximately eight million people every year, and on the other hand, M. bovis has the ability to infect a broader host range including domestic and wild animals. M. bovis can cause pathology in cattle and humans as well, yet rarely transmits between immuno-competent human hosts. Some reports have suggested an increase in the number cases of human TB caused by M. bovis , where probably inadequate disease control measures in animals and humans, a rise in the incidence of immunosuppressive diseases, and the close physical contact between humans and animals facilitate the transmission of M. bovis from animals to human hosts [1].

Cattle bovine tuberculosis pathology as a consequence of M. bovis infection induces comparable immune responses to those seen in humans. Heterogeneity in granuloma type is commonly found during human and bovine TB, and lesions are predominantly localized to the respiratory tract and associated lymphatic tissue, leading a chronic disease that may take years to develop. Ten to thirty percent of the humans who are naturally exposed to M. tuberculosis get infected, where 10-40% of immuno-competent hosts develop an active TB. Disease manifestation is reached often within a year after infection, or later in life. In most immune-competent infected people, the chronic form of TB will remain latent and will not progress.

In recent years, research has been made aiming to define the molecular basis that might, at least partially, explain how virulent mycobacteria are able to remain in a persistent or latent infection state in its human host and how these bacteria could resuscitate and be able to promote an active phase of disease [2]. A number of studies have suggested that in M. tuberculosis the DosR regulon (48 genes induced by stresses such as hypoxia, nitric oxide, and during granuloma formation) plays a role in inducing a chronic infection and persistence in animal laboratory models that resemble human infection in some respects. Latency is the product of interaction between host and mycobacteria, and is defined as the persistence of a tuberculous lesion with viable mycobacteria in a host without symptoms and has been demonstrated because of reactivation of apparently healthy people and/or reactivity towards mycobacterial antigens. Cavitation is thought to be the condition that causes bacteria to go into the metabolically and morphologically distinct dormant state. It is relevant to note that caseous tubercles that lead to cavitation do form in cattle

In bovines, most studies have focused on active disease and related immune responses, and only a few studies have suggested an existence of latent TB [3]. Human latent TB infection (LTBI) was first described because a tuberculin skin test (TST) positive was observed in clinically healthy people. Nowadays, interferon-gamma release assays (IGRA) using mycobacterial specific antigens are considered a complementary test to TST by international guidelines, and even TST and IGRA tests have allowed to suggest that LTBI due to M. bovis could be present even in cattle. Even so, we propose that LTBI could be defined as the existence of a positive TST or IGRA test in cattle without visible lesions, a concept that will surely evolve as more biomarkers become available. In fact, cases of LTBI produced by M. bovis have been observed indirectly in healthy humans with overt active TB after antiinflammatory treatment [4].

Veterinary scientists regularly perform research addressing bovine TB directly in the target species, and research addressing human TB is performed using mice, guinea pigs, rabbits, and monkeys as models. Unfortunately, bovine TB is not generally regarded as a model for human TB. In guinea pigs and in sensitive and resistant mouse models, there is less inter individual variation and all animals succumb from infection with M. tuberculosis. The same holds for sensitive and resistant rabbits experimentally infected with M. bovis . The advantages of rabbits and guinea pigs over mice are known to be their sensitivity to tuberculous bacteria, and the resemblance of their lung pathology to human lung pathology. All mice, rabbits, and guinea pigs show progressive lung pathology, independent from whether bacterial loads are stationary or increasing. Rabbits and guinea pigs form cavitations, but they show progressive disease in multiple tissues, and do not go through a period of clinical latency.

Results from our laboratory have led us to propose that, in analogy to human TB, it is possible that bovine TB indeed would have a latent phase of infection, and we hence have started to unravel this hypothesis directly in bovines based on the expression pattern of mycobacterial DosR genes in animal tissue of tuberculin-test reactors [5]. In cattle, the outcomes of exposure to M. bovis shows inter individual differences, resembling the situation in humans exposed to M. tuberculosis [6]. Furthermore, similar to what is observed in humans, some infected cattle would clear the infection, however remnant immune responses and perhaps mycobacteria would be responsible of bovine immune responses turn TST positive and/or their blood cells release interferon-gamma upon stimulation with mycobacterial antigens, but they show no clinical signs of disease, no visible lesions are present when slaughtered, and M. bovis cultures are negative, therefore strongly suggesting they are subjects of a LTBI. Nowadays, a LTBI experimental model in cattle is missing. So, even though cattle may be the species in which chronic infection resembles human latency optimally, we acknowledge that it is still a long road before we can categorically define that there is a latent stage in bovine TB, for example for testing post exposure vaccines against latency antigens.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11571
  • [From(publication date):
    October-2014 - Dec 13, 2017]
  • Breakdown by view type
  • HTML page views : 7801
  • PDF downloads : 3770
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version